Original from: bjzjqx.com

 

Overview of the industry

 

Globally, due to the earlier development of the in vitro diagnostic industry, the components manufacturers have occupied a large market share after years. 

 

Among them, IDEX of the United States mainly provides plunger pumps for automatic biochemical analyzer and automatic chemiluminescence immunoassay analyzer. IWAKI of Japan mainly provides non-valve plunger pumps for automatic chemiluminescence immunoassay analyzer and BODY Company of Germany, and SMC of Japan mainly provides solenoid valves for automatic biochemical analyzer, automatic chemiluminescence immunoassay analyzer, and five-classification blood analyzer. Burkert of Germany and SMC mainly provide solenoid valves for automatic biochemistry analyzer, automatic chemiluminescence immunoassay analyzer and five-sort blood analyzer, and Ito of Japan, Takasago of Japan, and UNIMED of Switzerland mainly provide spiking needles for high-end automatic biochemistry analyzer and automatic chemiluminescence immunoassay analyzer.

 

Chinese IVD instrument industry started late and began to gradually specialize only after 2001 with a small number of small and medium-sized enterprises specializing in the customized R&D and production of diagnostic instruments. 

 

At that time, the types of customized R&D instruments were limited, and most of them only focused on a single application field, with a low demand for related parts and components. After nearly two decades of development, the Chinese IVD instrument manufacturers and related parts and components enterprises have gradually grown up. 

 

 

Market size analysis

 

The global IVD instruments market size was USD 13.09 billion in 2016 and is growing steadily at a CAGR of 5.2% during 2016-2020 to reach USD 16.06 billion by 2020. It is expected to grow at an accelerated pace to reach USD 32.75 billion by 2025, corresponding to a CAGR of 15.3% from 2020-2025. It is expected to grow at a rate of 11.6% from 2025-2030. Driven by technological innovation and growing global demand, the global market size will grow to USD 56.66 billion by 2030.

 

Global In Vitro Diagnostic Instruments Market Size and Forecast 2016-2030

 

Chinese IVD instruments market grows from RMB 10.12 billion to RMB 22.32 billion by 2020 from 2016 to 2020, at a CAGR of 21.9%. Stimulated by favorable national policies and the growing demand, it is expected to reach RMB 60.99 billion in 2025 and RMB 114.62 billion in 2030, growing at a CAGR of 22.3% and 13.4% during the periods 2020-2025 and 2025-2030, respectively.

 

Chinese In Vitro Diagnostic Instruments Market Size and Forecast 2016-2030

 

 

Future Development Trends

 

In recent years, China's IVD industry has been growing rapidly at an annual growth rate of more than 15%, and the market capacity of China's IVD products has reached 70 billion yuan in 2018, becoming the fastest-growing market segment in the entire medical device industry. 

 

However, according to the national per capita calculation, China's annual expenditure on IVD per person is only about US$5, far lower than the average level of US$25-30 in developed countries and is still in the development stage of the industry's life cycle. 

 

With people's concern for health increasing, aging population intensifying and national policy support for the medical industry, and the continuous promotion of the construction of Healthy China, it is expected that in the next five years or even a longer period, China's IVD industry will still be in the golden age of rapid development, which will promote the development of IVD instrument industry!